The marketing of a disease: female sexual dysfunction
BMJPublished 20 January 2005Open access
Ray Moynihan
Citations323
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
Abstract
The pharmaceutical industry's dreams of making large profits from treating female sexual dysfunction are starting to look like premature speculation
Keywords
Medicine
JAMARisks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
15,680 Citations2002Jacques E. Rossouw
Overall health risks exceeded benefits from use of combined estrogen plus progestin for an average 5.2-year follow-up among healthy postmenopausal US women, and the results indicate that this regimen should not be initiated or continued for primary prevention of CHD.
JAMASexual Dysfunction in the United States
5,063 Citations1999Edward O. Laumann, Anthony Paik +1 more
The results indicate that sexual dysfunction is an important public health concern, and emotional problems likely contribute to the experience of these problems.
The Journal of UrologyREPORT OF THE INTERNATIONAL CONSENSUS DEVELOPMENT CONFERENCE ON FEMALE SEXUAL DYSFUNCTION: DEFINITIONS AND CLASSIFICATIONS
1,257 Citations2000Rosemary Basson, Jennifer R. Berman +17 more
Use of the new female sexual dysfunction diagnostic and classification system based on physiological as well as psychological pathophysiologies, and a personal distress criterion for most diagnostic categories are recommended.
BMJSelling sickness: the pharmaceutical industry and disease mongeringCommentary: Medicalisation of risk factors
881 Citations2002R. Moynihan, Peter C G⊘tzsche +2 more
Some forms of medicalising ordinary life may now be better described as disease mongering: widening the boundaries of treatable illness in order to expand markets for those who sell and deliver treatments.
Archives of Sexual BehaviorDistress About Sex: A National Survey of Women in Heterosexual Relationships
776 Citations2003John Bancroft, Jeni Loftus +1 more
In general, the predictors of distress about sex did not fit well with the DSM-IV criteria for the diagnosis of sexual dysfunction in women, and the conceptual issues involved in the use of terms such as “ sexual problem” and “sexual dysfunction” are discussed.
The Journal of Sexual MedicineRevised Definitions of Women's Sexual Dysfunction
445 Citations2004Rosemary Basson, Sandra R. Leiblum +11 more
The International Definitions Committee has recommended a number of fundamental changes to the existing definitions of women's sexual disorders based on an alternative model reflecting women's reasons/incentives for sexual activity beyond any initial awareness of sexual desire.
International Journal of Impotence ResearchVasculogenic female sexual dysfunction: The hemodynamic basis for vaginal engorgement insufficiency and clitoral erectile insufficiency
241 Citations1997Kwangsung Park, Irwin Goldstein +4 more
Vaginal engorgement and clitoral erection depend on increased blood inflow, and Atherosclerosis is associated with vaginal engorgements insufficiency and clitorAL erectile insufficient.
UrologyFemale sexual dysfunction: incidence, pathophysiology, evaluation, and treatment options
218 Citations1999Jennifer R. Berman, Laura Berman +1 more
Based on the understanding of the physiology of the male erectile response, recent advances in modern technology, and the recent interest in Women’s Health issues, the study of female sexual dysfunction is gradually evolving and future advances in the evaluation and treatment of femaleSexual health problems are forthcoming.
Urologic Clinics of North AmericaFEMALE SEXUAL DYSFUNCTION
183 Citations2001Jennifer R. Berman, Irwin Goldstein
Australian and New Zealand Journal of Public HealthSex in Australia: Sexual difficulties in a representative sample of adults
180 Citations2003Juliet Richters, Andrew E. Grulich +3 more
The Australian Study of Health and Relationships reports on sexual behaviours in a representative sample of Australian adults and finds that young people are more sexually active than older people and are more likely to have a sexual relationship with a partner.
A New View of Women's Sexual Problems
180 Citations2014Ellyn Kaschak, Leonore Tiefer
Archives of Sexual BehaviorThe Medicalization of Female Sexual Dysfunction: The Need for Caution
145 Citations2002John Bancroft
The use of drugs such as Viagra to treat sexual dysfunction in women may be beneficial in a proportion of cases, however, there are a number of barriers to understanding and predicting which women are likely to benefit, and caution is required in approaching this clinical issue.
Journal of Sex & Marital TherapyEffect of Sildenafil on Subjective and Physiologic Parameters of the Female Sexual Response in Women with Sexual Arousal Disorder
138 Citations2001Jennifer R. Berman, Laura Berman +5 more
Sildenafil appears to significantly improve both subjective and physiologic parameters of the female sexual response in women with sexual arousal disorder (SAD).
The Journal of Sex ResearchSexology and the pharmaceutical industry: The threat of co‐optation
86 Citations2000Leonore Tiefer
BMJFDA panel rejects testosterone patch for women on safety grounds
23 Citations2004Ray Moynihan
A panel of advisers to the US Food and Drug Administration last week unanimously rejected an experimental testosterone patch as a treatment for women with sexual difficulties.
International Journal of Impotence ResearchEvaluation of the alleviative action of neurotropin for penile pain associated with intracavernous injection of prostaglandin E1 assessed using the visual analogue scale
8 Citations1998Yoshikazu Sato, Nobukazu Suzuki +4 more
It is concluded that neurotropin may be an effective and safe drug for penile pain associated with PGE1 intracavernous injection.